Love-Sick and Beyond: Understanding Bipolar Disorder Through the Onija Andrew Robbins and Kanye West
Bipolar disorder, one of the most diagnosed mental health conditions after anxiety and clinical depression, affects about 2.8% of the global population.
Characterized by extreme mood swings, the disorder can significantly impact an individual's daily life, relationships, and overall well-being. What is Bipolar Disorder?
Bipolar disorder, previously known as manic depression, is a mental health condition marked by alternating episodes of mania (or hypomania) and depression. These episodes can last for days, weeks, or even months, and their intensity varies from person to person.
During manic episodes, individuals experience emotional highs, characterized by euphoria, increased energy, and impulsive behaviors, while depressive episodes bring feelings of sadness, hopelessness, and loss of interest in daily activities.
The disorder is more than just moodiness; it's a serious mental illness that can disrupt relationships, careers, and overall quality of life. According to the World Health Organization (WHO), bipolar disorder affects approximately 45 million people worldwide.
Despite its prevalence, it remains widely misunderstood, often stigmatized, and sometimes misdiagnosed. Types of Bipolar Disorder Bipolar I Disorder:
This type is defined by at least one manic episode, which may be preceded or followed by hypomanic or depressive episodes. Mania can be severe enough to require hospitalization. Bipolar II Disorder:
Characterized by a pattern of depressive episodes and hypomanic episodes, but not full-blown mania. Cyclothymic Disorder:
A milder form involving periods of hypomanic symptoms and depressive symptoms lasting for at least two years. Other Specified and Unspecified Bipolar Disorders:
Symptoms that do not fit the above categories but still cause significant distress. Symptoms of Bipolar Disorder
Manic Episodes: Elevated mood
Increased energy
Reduced need for sleep
Impulsivity
Risky behavior
Depressive Episodes: Persistent sadness
Loss of interest in activities
Fatigue
Feelings of worthlessness
Suicidal thoughts Real-Life Stories: Onija Andrew Robbins and Kanye West Onija Andrew Robbins
'Call my husband Nidal,' Robbins kept saying throughout Wednesday night as she sat in the parking lot of Ali Arcade. (Image via Express)
Onija Andrew Robbins, a 35-year-old American woman, found herself at the center of an emotional whirlwind that ultimately led to her diagnosis of bipolar disorder. Robbins, a mother of two, traveled to Karachi, Pakistan, driven by her intense feelings for a 19-year-old Pakistani man, Nidal Ahmed Memon.
She claims to have married him online via the International Utah website. Despite her visa expiring, Robbins refuses to return home without Nidal, who has been in hiding due to the media spotlight surrounding their relationship.
Robbins is currently receiving treatment for bipolar disorder at the Special Ward of Jinnah Postgraduate Medical Centre (JPMC) in Karachi. The medical staff at JPMC has been continuously evaluating her condition, a challenge Robbins has faced both in the United States and abroad.
Her symptoms, including periods of heightened energy and emotional instability, led her to seek help, eventually resulting in her bipolar disorder diagnosis.
According to Robbins, her love-sick emotions went beyond the ups and downs of a typical romantic relationship. "Her symptoms, which included periods of heightened energy and deep despair, prompted her to seek medical help," as reported by The Express Tribune.
For Robbins, the diagnosis was both a revelation and a challenge. It explained her erratic behavior and emotional instability. Kanye West's Journey: A Public Struggle with Bipolar Disorder
Getty Images
Kanye West, now known as Ye , has been open about his struggles with bipolar disorder, which he was diagnosed with in 2018.
In the past, Ye referred to his bipolar disorder as his 'superpower,' though recently, he has questioned the accuracy of this diagnosis. During a podcast with Justin Laboy, Ye revealed that he now believes he may actually be autistic.
"I was misdiagnosed with bipolar disorder,' Ye explained during the podcast. He further clarified that his wife encouraged him to see a doctor who had also worked with Justin Bieber, leading him to reconsider his diagnosis.
Over the years, Ye's public struggles with mental health have garnered widespread media attention, from his social media outbursts to controversial statements. Despite the ongoing concerns over his mental well-being, Ye has continued to speak publicly about the challenges of living with a condition that has shaped much of his career and personal life. Living with Bipolar Disorder
Living with bipolar disorder requires a combination of medication, therapy, and lifestyle adjustments. Early diagnosis and treatment are crucial for managing symptoms and improving the quality of life.
However, stigma and misinformation often prevent individuals from seeking help. Robbins' story is a testament to the importance of seeking help and the power of breaking the stigma surrounding mental health.
As Robbins has shown, bipolar disorder does not discriminate. It can affect anyone, regardless of their background or personal experiences. However, societal stigma often prevents individuals from seeking help, as many fear being labeled as "unstable" or "unpredictable."
This can lead to isolation and untreated symptoms. Experts emphasize the importance of early diagnosis and treatment. With the right combination of medication, therapy, and lifestyle changes, individuals with bipolar disorder can lead fulfilling lives.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Recorder
2 hours ago
- Business Recorder
WHO maintains mpox alert amid West Africa surge
GENEVA: The World Health Organisation said Monday that the mpox virus epidemic remains an international health emergency with more than 37,000 confirmed cases reported since it erupted. WHO director general Tedros Adhanom Ghebreyesus announced the extension of the emergency following a meeting of international experts who noted progress in some countries but also highlighted a surge in west Africa and the spread of the virus outside Africa. The WHO said since the epidemic started in early 2024 in Democratic Republic of Congo, there have been more than 37,000 cases in 25 countries, including 125 deaths. Mpox: health dept for ensuring strict screening steps at Karachi airport DR Congo accounts for 60 percent of the confirmed cases and 40 percent of the deaths from the virus, that causes a rash and severe flu-like symptoms. Uganda and Burundi have been the next worst hit, followed by Sierra Leone, which the WHO said has seen a surge in cases this year. WHO first declared mpox an international emergency in August last year. The International Health Regulations emergency committee met last Thursday to discuss the epidemic. It decided that the epidemic remains an international emergency "based on the continuing rise in the number of cases, including a recent increase in West Africa, and likely ongoing undetected transmission in some countries beyond the African continent." It said some countries were still struggling to monitor the epidemic and with a lack of funding for treatment there was a need for "continued international support".
Express Tribune
3 days ago
- Express Tribune
Heat, power cuts risk Eid meat storage
Deep freezers bought by customers for keeping sacrificial meat are piled up outside the showrooms at Regal Chowk for delivery. Photo: Jalal Qureshi/express Intense heat and prolonged load-shedding during Eidul Azha have made preserving sacrificial meat a serious concern. Health experts advise drying washed meat thoroughly, cutting it into small portions, and storing it in airtight containers or polythene bags before freezing. Dr Hilar Sheikh of Jinnah Hospital told Express News that improper drying or delayed freezing can lead to spoilage. He warned against using regular plastic bags, which fail to block freezer gases, causing toxins to form. Repeated freezing and thawing may also cause food poisoning or hepatitis E. In case of outages, storing meat in ice-packed steel or thermocol boxes is advised. Early distribution to the needy is encouraged to avoid waste.
Business Recorder
3 days ago
- Business Recorder
Pakistan's vaccine independence: a national imperative
Pakistan stands at a critical crossroads in public health policy. With seven million births annually and a population growth rate of 2.55%, our nation faces an unprecedented challenge in vaccine security that demands immediate and decisive action. The looming withdrawal of GAVI support by 2031 presents not just a crisis, but an opportunity to transform Pakistan into a self-reliant pharmaceutical powerhouse. The stark reality we face The numbers paint a sobering picture of our current vulnerability. Pakistan's complete dependency on donated and discounted vaccine supplies, supported by GAVI, UNICEF, and WHO to the tune of PKR 26 billion annually, masks a deeper structural weakness. When GAVI's support ends in 2031, the financial burden will balloon to PKR 100 billion annually as nearly four times our current federal health budget of PKR 27 billion. This dependency is not merely financial; it represents a fundamental threat to national health security. This isn't just underdevelopment—it's a systematic surrender of national health autonomy. Today, Pakistan produces virtually no antigens for the Expanded Programme on Immunization (EPI) vaccines domestically. We lack essential seed banks, have minimal university-based vaccine development programs, and operate with regulatory guidelines that are inadequate for sophisticated vaccine manufacturing. Our clinical trial expertise remains severely limited, creating bottlenecks in bringing locally developed vaccines to market. The contrast with global pharmaceutical leaders is stark. While universities worldwide have been the birthplace of revolutionary vaccines-from the Hepatitis B vaccine developed at UC San Francisco to the Oxford-AstraZeneca Covid-19 vaccine-Pakistan's academic institutions remain largely disconnected from commercial vaccine production. Learning from global success stories International experience offers valuable lessons. India transformed itself into the 'pharmacy of the world' through strategic government support for generic manufacturing and robust regulatory frameworks. Singapore built a biomedical hub through integrated research, manufacturing, and regulatory excellence that attracted billions in global pharmaceutical investment. South Korea's government-industry partnerships created world-class biopharmaceutical capabilities. These success stories share common elements: sustained government commitment, strategic investment in infrastructure, regulatory excellence, and comprehensive talent development programs. Most importantly, they demonstrate that with the right approach, developing nations can achieve pharmaceutical self-sufficiency and even become global exporters. The Triple Helix solution The path forward requires unprecedented coordination between government, academia, and industry -what experts call the 'Triple Helix' approach. Each sector must play a distinct yet interconnected role in building national vaccine capacity. Government leadership is essential in creating policy frameworks that incentivize domestic production while providing funding for university research. Strategic assignments to national research institutions like the National Institute of Health, Centre of Excellence in Molecular Biology (CEMB), National Institute for Biotechnology and Genetic Engineering (NIBGE), International Centre for Chemical and Biological sciences (ICCBS), Karachi University, Department of Biotechnology, Dow University of Health Sciences (DUHS), etc., can accelerate vaccine development and establish crucial seed banks. Most critically, the government must develop a comprehensive national health security strategy that positions vaccine self-sufficiency as a matter of national defense. The regulatory transformation cannot be understated. Pakistan's Drug Regulatory Authority must achieve WHO Level 3 qualification and create 'regulatory sandboxes — collaborative environments where university researchers, industry partners, and regulatory experts jointly develop guidelines for the 13 critical EPI vaccine antigens. Fast-track approval pathways and clear regulatory roadmaps will accelerate the journey from laboratory research to commercial production. Formation of sandboxes by bringing together leaders of the University, Regulatory and Industry. Universities must step up as innovation engines. Institutions with BSL-III laboratories should lead development of live attenuated vaccines, while biotechnology departments focus on recombinant vaccine technologies. Specialized vaccine research centers, industry-relevant curricula, and technology transfer offices will bridge the gap between academic discovery and commercial application. State-of-the-art pilot manufacturing facilities will provide proof-of-concept capabilities essential for scaling innovations. Industry brings manufacturing excellence and market expertise to the equation. Private sector partners can transform academic research into GMP-compliant commercial production, establish robust supply chains for raw materials, and navigate complex regulatory approvals. Their distribution networks and market access capabilities will ensure that domestically produced vaccines reach every corner of Pakistan. Leading companies in Pakistan already in the field of Biopharmaceutical manufacturing must be involved in the development process. A realistic implementation roadmap Success requires a phased approach spanning six years. The foundation phase (Years 1-2) must establish policy frameworks and coordination mechanisms while launching capacity-building programmes. Infrastructure development (Years 2-4) involves scaling laboratory manufacturing capabilities, establishing vaccine testing facilities, and launching pilot production programs. The scale-up phase (Years 4-6) transitions to commercial production of EPI vaccines, regulatory approvals, and distribution network establishment. Finally, the optimization phase (Year 6+) expands manufacturing capabilities, develops advanced biologics production, and positions Pakistan as a regional pharmaceutical hub. Financial innovation will be crucial. Blended financing models combining public funding, private investment, and support from institutions like the Islamic Development Bank can mobilise the substantial capital required for drug substance manufacturing facilities. The initial investment may be significant, but the long-term savings and export potential far outweigh the costs. The economic and strategic imperative The benefits extend far beyond health security. A robust domestic vaccine industry could create over 5,000 jobs and reduce import dependency by 50 percent. More importantly, it would establish Pakistan as a regional pharmaceutical hub with significant export potential to neighboring countries and the broader Islamic world. The Covid-19 pandemic demonstrated the critical importance of pharmaceutical self-reliance. Nations with domestic production capabilities could respond rapidly to their populations' needs, while others waited months for external supplies. This lesson cannot be ignored as we face an uncertain global health landscape. The time for action is now Pakistan's demographic dividend — with 65 percent of the population under 30 — represents an unprecedented opportunity to build a knowledge-based pharmaceutical sector. However, this window will not remain open indefinitely. The GAVI deadline of 2031 provides a clear timeline for action, but preparation must begin immediately. The success of this transformation depends on political will, sustained investment, and most importantly, recognition that vaccine self-sufficiency is not a luxury but a national security imperative. Countries that fail to develop domestic pharmaceutical capabilities will remain perpetually vulnerable to supply disruptions, price volatility, and foreign policy pressures. A call to national action The establishment of National and Provincial Coordination Committees bringing together leaders from academia, industry, and regulatory agencies represents the essential first step. This must be followed by a comprehensive assessment of current capabilities, development of a detailed national vaccine strategy, and launch of pilot programmes for immediate impact. Pakistan has the intellectual capital, institutional foundation and market potential to achieve vaccine independence. What we need now is the collective will to transform this potential into reality. The health and prosperity of future generations depend on the decisions we make today. The choice is clear: remain dependent on the goodwill of international donors or invest in building a self-reliant pharmaceutical sector that serves not only Pakistan's needs but positions the nation as a leader in global health innovation. The Triple Helix approach offers a proven pathway to pharmaceutical independence-we must have the courage to take it. Copyright Business Recorder, 2025
